首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Insights from capillary electrophoresis approaches for characterization of monoclonal antibodies and antibody drug conjugates in the period 2016-2018
【24h】

Insights from capillary electrophoresis approaches for characterization of monoclonal antibodies and antibody drug conjugates in the period 2016-2018

机译:毛细管电泳方法的见解,用于在2016 - 2018年期间表征单克隆抗体和抗体药物缀合物的表征

获取原文
获取原文并翻译 | 示例
           

摘要

Monoclonal antibodies (mAbs) and their related products as antibody-drug-conjugates (ADCs) or biosimilars represent a constantly growing class of molecules therapeutic proteins used as treatment against numerous diseases, These compounds can undergo several modifications which could alter the efficiency of treatments. In this context, several analytical methods were designed to deliver a comprehensive structural characterization and guarantee the quality of biotherapeutics. Capillary electrophoresis (CE) is considered today as a major technique for the analysis of biotherapeutics due to benefic characteristics as high resolution separation and miniaturized format. Different CE modes have been developed to characterize mAbs at different levels such as capillary gel electrophoresis (CGE), capillary isoelectric focusing (cIEF), and capillary zone electrophoresis (CZE). Recent developments in CE-mass spectrometry (MS) coupling assessed this technology as a promising tool to obtain high level structural characterization of biopharmaceuticals. Moreover, upcoming techniques such as 2D CE-MS and microfluidic systems are now emerging to offer new possibilities beyond actual limits. This review will be dedicated to discuss the state-of-the-art CE-based methods for the characterization of mAbs and ADCs in the period 2016-2018.
机译:单克隆抗体(MAB)及其相关产品作为抗体 - 药物 - 缀合物(ADC)或生物仿制物代表不断种植的分子治疗蛋白,用于针对许多疾病的治疗,这些化合物可以经历几种改变治疗效率的修饰。在这种情况下,旨在提供综合结构表征并保证生物治疗方法的综合结构表征。目前认为毛细管电泳(CE)是由于受益特征为高分辨率分离和小型化格式而分析生物治疗剂的主要技术。已经开发出不同的CE模式以表征不同水平的MAB,如毛细血管凝胶电泳(CGE),毛细管等电聚焦(凸型)和毛细管区电泳(CZE)。 CE质谱(MS)耦合的最新进程评估了该技术作为获得生物制药的高水平结构表征的有希望的工具。此外,即将到来的技术,如2D CE-MS和微流体系统现在正在出现以提供超出实际限制的新可能性。该审查将致力于讨论2016 - 2018年期间拟订MAB和ADC的最先进的基于CE的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号